These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 5760501)

  • 41. Chloroform inactivation of reovirus hemagglutinins.
    Rozee KR; Leers WD
    Can Med Assoc J; 1967 Mar; 96(10):597-9. PubMed ID: 4960135
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Purification of vaccinia haemagglutinin.
    Gurvin I; Haukenes G
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1973 Oct; 81(5):563-6. PubMed ID: 4525070
    [No Abstract]   [Full Text] [Related]  

  • 43. [Purifying the vaccinia virus vaccine by gel filtration].
    Stickl H; Korb W; Hochstein-Mintzel V
    Zentralbl Bakteriol Orig; 1970; 215(1):38-50. PubMed ID: 5487818
    [No Abstract]   [Full Text] [Related]  

  • 44. Purification of Newcastle disease virus by chromatography on controlled-pore glass bead column.
    Rosenbergová M; Marcinka K; Pristasová S
    Acta Virol; 1981 Jan; 25(1):31-5. PubMed ID: 6112863
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rubella virosomes: preparation and ultrastructure.
    Trudel M; Marchessault F; Payment P
    J Virol Methods; 1981 Nov; 3(4):187-92. PubMed ID: 7328160
    [TBL] [Abstract][Full Text] [Related]  

  • 46. K2-tartarate gradient centrifugation in the isolation of purified influenza virus haemagglutinin after bromelain cleavage.
    Hils J; May A; Neubert G; Domnick E; Pohl G; Liebe C
    Acta Virol; 1983 Nov; 27(6):470-6. PubMed ID: 6140831
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The density of the foot-and-mouth disease virus in CsCl solutions].
    Liebermann H
    Arch Exp Veterinarmed; 1973; 27(6):939-44. PubMed ID: 4365551
    [No Abstract]   [Full Text] [Related]  

  • 48. Zonal density gradient electrophoresis of influenza A virus.
    Rosenbergová M; Slávik I; Hána L
    Acta Virol; 1981 Mar; 25(2):78-86. PubMed ID: 6113753
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rapid DNA preparation from bees and %GC fractionation.
    Beye M; Raeder U
    Biotechniques; 1993 Mar; 14(3):372-4. PubMed ID: 7681294
    [No Abstract]   [Full Text] [Related]  

  • 50. Genetic recombination between vaccinia virus strains distinct in hemagglutinin production and plaquing efficiency.
    Ando N; Matsumoto M
    Jpn J Microbiol; 1968 Dec; 12(4):495-504. PubMed ID: 5304283
    [No Abstract]   [Full Text] [Related]  

  • 51. Analysis of the hemagglutinin glycoprotein from mutants of vaccinia virus that accumulates on the nuclear envelope.
    Shida H; Matsumoto S
    Cell; 1983 Jun; 33(2):423-34. PubMed ID: 6861204
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Concentration and purification of rubella virus hemagglutinin by hollow fiber ultrafiltration and sucrose density centrifugation.
    Trudel M; Payment P
    Can J Microbiol; 1980 Nov; 26(11):1334-9. PubMed ID: 7214222
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The haemagglutinins of adenovirus types 26, 9, and 9-15].
    Breug R; Wigand R
    Zentralbl Bakteriol Orig; 1970; 214(1):1-8. PubMed ID: 5528284
    [No Abstract]   [Full Text] [Related]  

  • 54. Influence of the physical state of formalinized vaccinia virus particles on surviving plaque titer: evidence for multiplicity reactivation.
    Kim KS; Sharp DG
    J Immunol; 1967 Dec; 99(6):1221-5. PubMed ID: 6060970
    [No Abstract]   [Full Text] [Related]  

  • 55. Genetic stability of Newcastle disease virus CG179: a strain containing only clear plaque subpopulations.
    McMillan BC; Hanson RP
    Avian Dis; 1983; 27(3):787-91. PubMed ID: 6639553
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Isolation of the complementary strands of vaccinia virus DNA.
    Pogo BG
    Intervirology; 1981; 15(3):161-4. PubMed ID: 6895214
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Method for the purification and concentration of Vaccinia-virus.
    Orlov G; Gancheva T; Kavaklova L; Vacheva V
    Zentralbl Bakteriol Orig A; 1972 Nov; 222(2):174-9. PubMed ID: 4144792
    [No Abstract]   [Full Text] [Related]  

  • 58. Identification and analysis of vaccinia virus palmitylproteins.
    Grosenbach DW; Hansen SG; Hruby DE
    Virology; 2000 Sep; 275(1):193-206. PubMed ID: 11017799
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Use of anaplyxasis for evaluating the reactogenicity of commercial strains and series of a vaccine virus].
    Vorob'ev AA; Afanas'ev SS; Patrikeev GT; Podkuĭko VN; Pashanina TP
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Aug; (8):14-7. PubMed ID: 494895
    [No Abstract]   [Full Text] [Related]  

  • 60. Infection with vaccinia favors the selection of hybridomas synthesizing autoantibodies against intermediate filaments, one of them cross-reacting with the virus hemagglutinin.
    Dales S; Fujinami RS; Oldstone MB
    J Immunol; 1983 Sep; 131(3):1546-53. PubMed ID: 6684139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.